Comparing Nutritional Status of In-centre Nocturnal Hemodialysis Patients to Conventional Hemodialysis Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02887391 |
Recruitment Status : Unknown
Verified August 2016 by Dr Jennifer MacRae, University of Calgary.
Recruitment status was: Enrolling by invitation
First Posted : September 2, 2016
Last Update Posted : September 2, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
End Stage Renal Failure on Dialysis | Other: No intervention - observational study |
Study Type : | Observational |
Estimated Enrollment : | 20 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Comparing Nutritional Status of In-centre Nocturnal Hemodialysis Patients to Conventional Hemodialysis Patients: A Prospective Cohort Study |
Study Start Date : | January 2016 |
Estimated Primary Completion Date : | June 2017 |
Estimated Study Completion Date : | June 2017 |
Group/Cohort | Intervention/treatment |
---|---|
Conventional Hemodialysis
Control group 4 hours of hemodialysis 3x per week (12 hours hemodialysis/week)
|
Other: No intervention - observational study
No intervention - observational study |
In-Centre Nocturnal Hemodialysis
8 hours of hemodialysis 3x per week (24 hours hemodialysis/week)
|
Other: No intervention - observational study
No intervention - observational study |
- Malnutrition Inflammation Score (MIS) [ Time Frame: Baseline & 6 months ]A survey/tool that uses both subjective global assessment and objective laboratory measures to evaluate nutritional status. Change from baseline MIS at 6 months will be measured in both groups.
- Quality of Life [ Time Frame: Baseline & 6 months ]KDQOL (SF-36) will be used to measure the quality of life in both groups at baseline and change after 6 months.
- Dietary Intake [ Time Frame: Baseline & 6 months ]3 day food records will be administered to document changes in dietary intake. Will be measured at baseline and change after 6 months in both groups.
- Appetite [ Time Frame: Baseline & 6 months ]Simplified Nutritional Appetite Questionnaire (SNAQ) will be administered to document changes in appetite. Will be measured at baseline and change after 6 months in both groups.
- Interdialytic Weight Gain [ Time Frame: Baseline & 6 months ]Measurement of fluid weight gain between dialysis sessions; Will be measured in both groups at baseline and after 6 months.
- Body Mass Index (BMI) [ Time Frame: Baseline & 6 months ]Body Mass Index (BMI) will be used to assess change in weight over time. Will be measured in both groups at baseline and after 6 months.
- Triceps Skinfold Thickness [ Time Frame: Baseline & 6 months ]Triceps skinfold thickness will be used to assess changes in muscle and fat mass over time. Will be measured in both groups at baseline and after 6 months.
- Mid Arm (Muscle) Circumference [ Time Frame: Baseline & 6 months ]Mid arm (muscle) circumference will be used to assess changes in muscle and fat mass over time. Will be measured in both groups at baseline and after 6 months.
- Handgrip Strength [ Time Frame: Baseline & 6 months ]Handgrip strength will be used to assess changes in muscle strength over time. Will be measured in both groups at baseline and after 6 months.
- Bio-electrical Impedance [ Time Frame: Baseline & 6 months ]This is completed as one measurement to assess body composition (fat, fluid, muscle). Will be measured at baseline and after 6 months in both groups.
- Serum Albumin [ Time Frame: Baseline & 6 months ]Serum albumin will be measured as part of hemodialysis standard of care. Change in baseline serum albumin will be evaluated at 6 months.
- C-reactive protein (CRP) [ Time Frame: Baseline & 6 months ]C-reactive protein will be measured as part of hemodialysis standard of care. Change in baseline CRP will be evaluated at 6 months.
- Total iron binding capacity (TIBC) [ Time Frame: Baseline & 6 months ]Total iron binding capacity (TIBC) will be measured as part of hemodialysis standard of care. Change in baseline TIBC will be evaluated at 6 months.
- Phosphate Binders [ Time Frame: Baseline & 6 months ]Changes in use and number/dose of phosphate binders will be measured at baseline and after 6 months in both groups.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- >18 years of age
- referred to the in-centre nocturnal hemodialysis program
- medically stable
- undergo hemodialysis three to four times per week for a minimum of three hours per week
- able to provide written, informed consent
Exclusion Criteria:
- younger than 18 years old
- have a current diagnosis with palliative status (e.g. cancer) or have active disease
- have had a prolonged hospitalization (>3 weeks) within the previous 3 months

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02887391
Canada, Alberta | |
Alberta Health Services Southern Alberta Renal Program | |
Calgary, Alberta, Canada, T2N 2T9 |
Principal Investigator: | Jennifer MacRae, MSc, MD | University of Calgary | |
Principal Investigator: | Tanis Fenton, PhD, RD | University of Calgary | |
Study Director: | Rebecca Holmes, BCom, BSc | University of Calgary |
Responsible Party: | Dr Jennifer MacRae, Associate Professor Medicine, University of Calgary |
ClinicalTrials.gov Identifier: | NCT02887391 |
Other Study ID Numbers: |
E-2358 |
First Posted: | September 2, 2016 Key Record Dates |
Last Update Posted: | September 2, 2016 |
Last Verified: | August 2016 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Plan Description: | Individual participant data will not be shared |
hemodialysis nutritional status |
Kidney Failure, Chronic Renal Insufficiency Kidney Diseases Urologic Diseases Renal Insufficiency, Chronic |